Literature DB >> 8799578

Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells.

D Erlinge1, M Heilig, L Edvinsson.   

Abstract

1. We and others have shown that extracellular ATP (adenosine triphosphate), released from sympathetic nerves and platelets, stimulates growth of vascular smooth muscle cells (SMC). To study the importance of tyrosine kinases for ATP-mediated proliferation in vascular smooth muscle cells we used tyrphostins, a recently developed group of highly specific inhibitors of tyrosine kinases. 2. ATP induced a powerful concentration-dependent increase in DNA synthesis measured by [3H]-thymidine incorporation in rat aorta SMC (RASMC) and an increase in total cell number after 72 h of incubation as measured by an enzymatic cell proliferation assay. Tyrphostin 25 (10(-5) M) had no effect per se on basal DNA synthesis but reduced ATP-stimulated DNA synthesis and increase in cell number in a dose-dependent manner. Higher concentrations of ATP could not reverse the inhibitory effect of tyrphostin 25. The potency of several (six) other tyrphostins was also examined and found to be slightly greater than tyrphostin 25 with equal efficacy. 3. When RASMC were incubated with 10(-5) M ATP for 2 h, nearly all of the cells (87 +/- 5%) were intensely stained with an antibody to the Fos protein while in the controls only 1 +/- 2% of the cells were weakly stained. Tyrphostin 25 greatly reduced the Fos-protein staining (14 +/- 2%). 4. ATP induced a concentration-dependent increase in 45Ca(2+)-influx and formation of inositol phosphates (IPtotal) in RASMC. These effects were not inhibited by tyrphostin 25. 5. Tyrphostin 25 did not alter ATP-induced contraction in ring segments of rat aorta. 6. In conclusion, tyrphostin 25 inhibited ATP-induced DNA synthesis, cell proliferation and Fos-protein expression, but not ATP-induced 45Ca(2+)-influx, inositolphosphate-production or vasoconstriction. This indicates that the mitogenic effect of ATP on vascular smooth muscle cells is dependent on tyrosine kinases in contrast to the contractile effect of ATP in blood vessels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799578      PMCID: PMC1909538          DOI: 10.1111/j.1476-5381.1996.tb15502.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

Review 1.  Tyrphostins as molecular tools and potential antiproliferative drugs.

Authors:  A Levitzki; C Gilon
Journal:  Trends Pharmacol Sci       Date:  1991-05       Impact factor: 14.819

2.  Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.

Authors:  A Gazit; N Osherov; I Posner; P Yaish; E Poradosu; C Gilon; A Levitzki
Journal:  J Med Chem       Date:  1991-06       Impact factor: 7.446

Review 3.  G protein-coupled receptors for ATP and other nucleotides: a new receptor family.

Authors:  E A Barnard; G Burnstock; T E Webb
Journal:  Trends Pharmacol Sci       Date:  1994-03       Impact factor: 14.819

4.  Bradykinin and bombesin rapidly stimulate tyrosine phosphorylation of a 120-kDa group of proteins in Swiss 3T3 cells.

Authors:  L M Leeb-Lundberg; X H Song
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

5.  Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB.

Authors:  D D Ginty; A Bonni; M E Greenberg
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

6.  Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters.

Authors:  D Erlinge; H Yoo; L Edvinsson; D J Reis; C Wahlestedt
Journal:  Am J Physiol       Date:  1993-10

7.  Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors.

Authors:  T J O'Dell; E R Kandel; S G Grant
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

8.  Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.

Authors:  G E Bilder; J A Krawiec; K McVety; A Gazit; C Gilon; R Lyall; A Zilberstein; A Levitzki; M H Perrone; A B Schreiber
Journal:  Am J Physiol       Date:  1991-04

9.  A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity.

Authors:  V M Rivera; C K Miranti; R P Misra; D D Ginty; R H Chen; J Blenis; M E Greenberg
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

10.  Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).

Authors:  M D Sauro; B Thomas
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

View more
  3 in total

1.  P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Pieter-Jan D F Guns; Jan Hendrickx; Tim Van Assche; Paul Fransen; Hidde Bult
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

2.  Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium.

Authors:  Masakazu Hirakawa; Masahiro Oike; Yuji Karashima; Yushi Ito
Journal:  J Physiol       Date:  2004-05-21       Impact factor: 5.182

3.  P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.

Authors:  Bryan C Tackett; Hongdan Sun; Yu Mei; Janielle P Maynard; Sayuri Cheruvu; Arunmani Mani; Andres Hernandez-Garcia; Nadarajah Vigneswaran; Saul J Karpen; Sundararajah Thevananther
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-09       Impact factor: 4.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.